Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If u don't want to hold AMBS just buy the dip and sell as it upticks toward a .13 close or morning run. Conference call is set for 4:15 est and guidance will be given (that's right, I said guidance on a penny play) on lympro commercialization. Should be an interesting close and open tomorrow.
Reading your tin foil thinking never gets old. Thanks for sharing your wisdom. I really think u should write an OTC trading book/ebook, or at least have someone co-author one from just your posts. You already have your chapters outlined. I would buy your first copy and think many others here would as well.
Tsuguy
I just saw a DRNE commercial on Fox News and was very graphical about the products. Unfortunately I am in a hotel in Dubuque, IA so I can't rewind it back for a re-watch. Wish I could because I want to see the several photos they showed.
I have been very busy with work lately and have not had a chance to keep up on WSGI news, but this seems very interesting and I will now have to catch up.
Conclusions: MANF is a conserved neuroprotective factor in the retina. MANF acts as an immune-modifying factor to limit cell loss following acute damage. This work will serve as a proof of concept to the use of tissue repair promoting factors as co-adjutants in stem cell regenerative therapies.
In addition, the Company has acquired an exclusive option to license said intellectual property.
Have been swamped with work...all business ventures firing at all cylinders on my side, which means more work for me. Trying to keep up with everything in motion, and AMBS homework has been lacking of late. I thought you would be up to speed on this...
Hope all is well, sir...including your back!
Is this new:
MANF's current lead indication is Retinitis Pigmentosa, and other applications including Parkinson's disease, and Wolfram's Syndrome. Additional applications for MANF may include Traumatic Brain Injury (TBI), myocardial infarction, antibiotic-induced ototoxicity and certain other rare orphan diseases currently under evaluation.
Right now the level 2 is showing thin on both sides for about .005 swing. It will be up to the market makers which way they want to take it. Sit back and see which way they take this. Still think holding is best play and accumulate on any further dips.
Looking forward to tomorrow.
I think the market makers will lower it one more time like they did last week to try and shake out final loose hands. All while they accumulate more for themselves into tomorrow. Watch for quick move up late into the day. IMO
I agree. Need to involve more like he. I think more will be in the know soon, which will dramatically improve stability and credence to the science.
I would prefer to see the healthcare community investing more heavily than the sport authorities. I think the healthcare community would be larger, more stable, and understand the full potential.
Although, the Najarian brothers on CNBC were former football players and could be great candidates to help promote $AMBS on Wall Street. Someone should reach out to them to inquire on interest of conference and company developments.
Good run followed by a healthy intraday pullback. This is looking good for a strong close and another strong day tomorrow. People won't want to be on the sidelines going into presentations.
Not much retail selling now. Looks like we are ready for a run thru .14
Five star post! You are exactly correct risk and those points are exactly what will move this company to the next level.
Looks like it was released yesterday according to this:
Check out our On The Street interview with Gerald Commissiong, CEO of Amarantus Bioscience (OTCQB: AMBS), a... http://t.co/vulQ1oK0I5
— New to The Street (@NewToTheStreet) July 9, 2014
10 Reasons Your Brand Should Host A Twitter Chat
POSTED BY LAUREN DUGAN
Twitter chats have exploded in popularity in recent years. Longtime veterans like #SMChat and #BlogChat are now joined by IBM’s weekly #BigDataMgmt chat, Whole Food’s weekly #wfmdish chat, and too many TV and celebrity-related chats to count.
Increasingly, brands are realizing that Twitter chats can be powerful marketing tools, helping them achieve very specific business goals.
Whatever your goals are, you might want to add Twitter chats into the mix to help reach them. Here are ten reasons why you should consider hosting a branded Twitter chat:
1. To learn about your customers
Twitter chats offer brands the chance to gain valuable insight into the needs, preferences and behaviors of their audience.
By hosting a chat, you define the conversation. And if you’re able to choose a topic that is of value to your audience, they’ll be more engaged and eager to offer their thoughts and opinions. Twitter chats have the potential to act as real-time customer surveys or market research – as long as the focus is on offering value to participants first, and research second.
And using Nestivity’s Tweetcast to host your chat, you’ll have access to the entire transcript for analysis even after the chat has ended.
2. To form one-on-one relationships with influencers
Another benefit brands see from Twitter chats is a deeper connection with key influencers and members of their community.
Research shows that marketing-induced consumer-to-consumer word of mouth generates more than 2x the sales of paid advertising. By identifying and connecting with the most active participants in your Twitter chat, your brand can potentially create an army of brand advocates happy to share product reviews and recommendations long after the chat has ended.
3. To connect with new, high quality followers
Twitter chats are great not just for deepening connections with current customers, but also expanding your network to include new, highly targeted Twitter followers that have the potential to become loyal customers. Tweets sent during a chat are searchable and appear on the sender’s timeline, so the potential reach is quite high. By hosting a chat, your brand could get its message in front of hundreds of new followers interested in your products or services.
4. To establish your brand as an authority
As the host of a chat, your brand will be the center of the hour-long conversation. This requires a significant amount of planning (how will you organize topics? Keep the conversation on track?), but the payoff makes it well worth it. Your tweets and username will be associated with the thought leadership generated during the chat, and – especially if you are able to host chats on a regular basis – your brand will be seen as an authority within your industry. This can lead to increased exposure, brand recognition, lead generation and more.
5. To improve your brand awareness and sentiment
Twitter chats can be great tools for brands to raise their public profile and improve sentiment.
Chat participants who are new to your brand will see your tweets front-and-center, and through retweets, search and organic timeline appearances awareness of your brand will increase. And those who are current followers will see that your brand is concerned with building a vibrant community – something that will make them feel more positively toward your brand.
6. As a promotional tool
There have been a number of Twitter chat etiquette guides that hammer home the message that brands should never directly promote themselves during a chat – and they’re not wrong. Chat participants join your conversation to learn, network and share ideas, not to be sold to. However, offering exclusive content or discounts/freebies to chat participants with a soft-sell attitude can be a great way to use a chat to attract new customers. Just be sure that the focus of the chat is not self-promotional, and that the promotions offered are of value to your audience.
7. To get feedback on your products and services
Many brands are using Twitter chats to test the waters before launching or changing their products and services. A chat can involve asking participants what they like and dislike about a certain type of product. Unless you’re a big-name brand, it is probably best to keep the chat general (“What features do you wish your car had?”) as opposed to specific (“What features do you like best about our car?”). This way, participants who are not current customers will be able to join in and offer their feedback, and the chat won’t feel too much like a focus group.
For an example of how you can use Nestivity’s Tweetcast to gather feedback, check out the chat hosted by influencer network Raynforest.
8. To learn about your industry
One of the reason participants join a Twitter chat is to share knowledge. As the chat’s host, your brand can establish a tone that is conducive to a collaborative atmosphere, encouraging your audience to discuss new thoughts and trends within your industry. Not only will this establish your brand as central to your industry, but it can also help you stay current.
9. To define your organization as one that gives back to the community, generates trust
As consumers grow increasingly distrustful of traditional advertising, it can be difficult for a brand to establish a true connection with their customers. By hosting a Twitter chat, you will show your audience that you are dedicated to giving back to the community, which in turn will generate trust.
Twitter chats that are focused on sharing knowledge, networking and fostering engagement – as opposed to selling a product or service – will be given the most credibility, and the brands behind these chats stand to establish a foothold in their consumers’ minds as a trusted, generous entity.
10. To provide customer support
Lastly, brands can use Twitter chats to provide customer support, potentially saving hundreds or thousands of dollars on support tickets. By hosting a regularly scheduled customer support chat, your brand can answer common questions before they become full-blown problems for your customers.
Using Tweetcasts to host your customer service chat, in combination with your Nest, can help create a culture of people-powered customer support.
http://www.nestivity.com/10-reasons-your-brand-should-host-a-twitter-chat/
Lol. I still expect an afternoon. Obviously didn't follow the normal drop and run like usual open trends.
I count about 6 active market makers vs what was 3 over our last run up. I suspect we will see a couple more get active after next week.
Agreed. Not much on the retail sale side for upper resistance.
Should break .12 within 10 minutes. Morning open shakeout then run!
Looks like the roadshow begins next week. Exciting days ahead for AMBS, Alzheimer's disease families, physicians and mankind.
Low...Btw, tomorrow afternoon the AMBS CEO is hosting a question answer session on twitter. I believe this follows one of your identifiers as the start of a pr cycle to watch for. He already announced that big news will be announced next week at an Alzheimer's conference as well.
Your thoughts would be appreciated on twitter q&a for dark side movement in penny land.
Everyone should be alerted with tomorrow's twitter session. This will mark the beginning of the PR blitz that I mentioned in previous posts to watch for. Once this PR train starts it won't stop for a couple weeks, IMO.
AMBS broke out of descending triangle yesterday with huge volume. Today it has continued upward. Looking for next run up once .12 is breached. Keep an eye on tomorrow's trading.
This is a good sign. If you see this many market makers trying to regulate a stock without a retail herd there is only one thing that could mean...it has attracted their attention and it is about to move or at least they also think so.
They are here for one reason and that is to make money off of the move as well. We have consistently increases mm participation but this is the most activity I have seen yet. But first they must also accumulate shares!
Bodes well for AMBS future. Just watch.
The only resistance appears to be just marketmakers and no retail selling.
Level 2 shows very little selling resistance up to .12 so this could move fast.
Let the chasing begin.
I expect today to have one quick walk down followed by a nice move up as we continue into close. Tomorrow should also be interestingly positive going into 'Twitter Thursday.'
AMBS is ready for run into next week. Look for explosion especially when .12 breaks. Bullish candle yesterday shows how little upper resistance there is.
CEO is to present 3 times next week at the Alzheimer's convention and release breakthrough data for a commercial ready AD test. He has made continuous mention of up list with extreme confidence and likely big pharma partnership to be announced in the coming weeks.
Longs have much of the float locked up and the management team is very very strong. I am talking huge pharma guys not penny land pharma quality (including the founder of Amgen).
Check it out...looks are free...Buyers make money
I like Gerald's continuous use of up-list confidence. He obviously has something in his back pocket of significant magnitude. The question is what and when will it be public knowledge?
A word of advice, news trumps charts TA.
"we believe this disease can serve as fertile ground for testing MANF as a disease-modifying treatment for Type-1 diabetes that can later be translated to the broader diabetes population."
See more at: http://www.thechairmansblog.com/amarantus-bioscience/fumihiko-urano/marching-towards-revolutionary-therapy-blindness-diabetes-wolfram-syndrome/?utm_source=rss&utm_medium=rss&utm_campaign=marching-towards-revolutionary-therapy-blindness-diabetes-wolfram-syndrome#sthash.VWvWmDMn.dpuf
Looks like .13 shouldn't be a problem.
New AMBS blog out: http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/2h-2014-milestones-ahead-position-amarantus-list/
Lol, I guess either way you are in for a .13 run. GL Low
Here is the pr on AMBS for funding agreement
Amarantus Closes Warrant Solicitation; Enters Into $20 Million Purchase Agreement With Lincoln Park Capital Fund, LLC
Download PDF
SAN FRANCISCO, March 10, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTC:AMBS) (Amarantus or the Company), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to endoplasmic reticulum stress, cell cycle dysregulation, neurodegeneration and apoptosis, announced today that it has closed on its previously announced Warrant Solicitation, which the Company elected to increase in size from $3.0M to $3.6M due to oversubscriptions. Concurrently, the Company entered into a purchase agreement with Lincoln Park Capital Fund, LLC ("LPC"), a Chicago-based institutional investor. LPC initially purchased 4.0 million shares of Amarantus' common stock at $0.10 per share for $400,000 and has committed to invest, at the sole option of Amarantus, up to an additional $19.6M of equity capital over the term of the purchase agreement. The total gross proceeds to the Company from these two transactions upon closing is $4M.
"The capital raised through our Warrant Solicitation and the access to capital from LPC increases our flexibility to achieve a number of key milestones for the Company, including commercializing our LymPro Blood Test for Alzheimer's disease, advancing the clinical testing of Eltoprazine into late-stage development and filing one or more INDs for MANF in orphan indications," said Gerald E. Commissiong, President & CEO of Amarantus. "Going forward, the Company can focus on executing its clinical development plan, commercialization strategy and intellectual property aggregation strategy, while maintaining a strong negotiating position with potential partners due to the improved access to capital this agreement provides."
During the 30-month term of the purchase agreement the Company, at its sole discretion, has the right to sell to LPC up to an additional $19.6 million of its common stock, in amounts as described in the agreement and subject to certain conditions, which include the effectiveness of a registration statement with the U.S. Securities and Exchange Commission (SEC) covering the sale of the shares that may be issued to LPC. The Company controls the timing and amount of any future investment and LPC is obligated to make purchases, if and when the Company decides in accordance with the agreement.
There are no upper limits to the price LPC may pay to purchase Amarantus common stock and the purchase price of the shares related to any future investments will be based on the prevailing market prices of the Company's shares immediately preceding the notice of sale to LPC. LPC has agreed not to cause or engage in any manner whatsoever, any direct or indirect short selling or hedging of the Company's shares of common stock. In consideration for entering into the agreement and the initial investment, the Company has issued shares of common stock to LPC as a commitment fee. The agreement may be terminated by the Company at any time, at its sole discretion, without any monetary cost. The proceeds from this investment will be used for product development, commercialization and general corporate purposes.
A more detailed description of the agreement is set forth in the Company's Current Report on Form 8-K recently filed with the SEC which the Company encourages be reviewed carefully.
This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities in this offering, nor will there be any sale of these securities in any jurisdiction in which such offer solicitation or sale are unlawful prior to registration or qualification under securities laws of any such jurisdiction.
Many think AMBS accumulation is from Lincoln park capital buying in the open market before shares are sold via funding agreement at the discretion of AMBS. This was a $20 million agreement. What is your thought of dark side accumulation at discounted prices prior an executed sale? Would this be enough dark side conspiracy to cause a double or triple prior to funding execution? If so what kind of target would u put on that investment funds return goal?
Do u ever look at any weekly charts? If so, when would you give it credence?
Morning gap up is now closed...ready for takeoff!
I think it is more the market makers trying to accumulate more here. There have been 2 of them that have been trading this closely over the last couple weeks, and now there is 3 closely trading the last couple days. This is usually a good sign that they have interest and want to get in on the trading before it explodes. Remember, they make money off this movement too...accumulation works for them too.
A couple more Lincoln Park stocks to watch for dark side action/movement in addition to AMBS: BLRX ASTM PLPL